,i #aahth ,,congress #ast ,session ,h4 ,r4 #bdjh ,,in ,,the ,,house ,,of ,,representatives ,march #cj1 #bjbc,ms4 ,barragn 7for herself and ,mr4 ,joyce of ,pennsylvania7 introduced the following bill2 which was referred to the ,committee on ,ways and ,means1 and in addition to the ,committee on ,energy and ,commerce1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to amend title ,,xviii of the ,social ,security ,act to provide a review process for adverse national coverage determinations with respect to drug coverage under the ,medicare program4 #a4 ,short title ,this ,act may be cited as the ,access to ,innovative ,treatments ,act of #bjbc4 #b4 ,providing a review process for adverse national coverage determinations with respect to drug coverage under the ,medicare program 7a7 ,in general ,section #ahfb7l7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciey7l77 is amended-- 7#a7 by redesignating paragraphs 7#e7 and 7#f7 as paragraphs 7#g7 and 7#h71 respectively2 and 7#b7 by inserting after paragraph 7#d7 the following new paragraphs3 7#e7 ,review of national coverage determinations for drugs and biologicals 7,a7 ,in general ,subject to subparagraph 7,d71 not later than #cj days after receiving a request for a review of a specified national coverage determination 7as defined in subparagraph 7,e771 the ,secretary shall initiate such a review in accordance with the provisions of this paragraph4 7,b7 ,public comment period ,beginning on the date of the initiation of a review of a specified national coverage determination under subparagraph 7,a71 the ,secretary shall provide for a #cj-;day public comment period as to whether such determination should be affirmed1 reversed1 or otherwise modified4 7,c7 ,final decision ,not later than #cj days after the conclusion of the #cj-;day period described in subparagraph 7,b7 with respect to a specified national coverage determination1 the ,secretary shall-- 7i7 make a final decision as to whether such determination should be affirmed1 reversed1 or otherwise modified2 7ii7 include in such final decision summaries of the public comments received and responses to such comments2 7iii7 make available to the public the clinical evidence and other data used in making such decision when such decision differs from the recommendations of the ,medicare ,coverage ,advisory ,committee2 and 7iv7 in the case of a final decision under clause 7i7 to reverse or modify such determination1 the ,secretary shall assign a temporary or permanent code 7whether existing or unclassified7 and implement the coding change as applicable4 7,d7 ,limitation on successive reviews ,subparagraph 7,a7 shall not apply with respect to a request for a review of a specified national coverage determination if the ,secretary has made a final decision with respect to a previous review of such determination under this paragraph during the #b-year period ending on the date of the receipt of such request4 ,nothing in the preceding sentence shall be construed to limit the authority of the ,secretary to review or reconsider a national coverage determination if determined appropriate by the ,secretary4 7,e7 ,specified national coverage determination defined ,in this paragraph1 the term specified national coverage determination means a national coverage determination made with respect to a drug or biological approved under section #eje7;c7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act or licensed under section #cea of the ,public ,health ,service ,act under which coverage of such drug or biological under this title was denied or otherwise limited in a manner inconsistent with such approval or licensure4 7#f7 ,prohibition on application of certain existing national coverage determinations to newly approved drugs and biologicals ,the ,secretary may not1 with respect to a drug approved under section #eje7;c7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act or a biological licensed under section #cea of the ,public ,health ,service ,act1 apply a national coverage determination that was made prior to the date of such approval or licensure 7as applicable7 to the extent that such application would result in a denial or other limit of coverage under this title for such drug or biological in a manner inconsistent with such approval or licensure4 4 7b7 ,nonreliance on certain ,n,c,ds under part ,d ,section #ahfj;,d-#b7;e77#c7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciew-#ajb7;e77#c77 is amended by adding at the end the following new sentence3 ,in determining whether payment would not be made with respect to a covered part ,d drug if section #ahfb7;a7 applied to this part1 a prescription drug plan or ,,ma-,,pd plan may not base such determination on a national coverage determination made with respect to such drug if such determination is a specified national coverage determination 7as defined in section #ahfb7l77#e7744